Crystalline Forms of Therapeutic Compounds and Uses Thereof (2017)
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,336,767 | Crystalline Forms of Therapeutic Compounds and Uses Thereof In force · High confidence | Kala Bio, Inc. | In force | High confidence | ||
| US 10,626,121 | Crystalline Forms of Therapeutic Compounds and Uses Thereof Lapsed Apr 21, 2024 on the fee record High confidence | Kala Bio, Inc. | Lapsed Apr 21, 2024 on the fee record | High confidence | ||
| US 11,104,685 | Crystalline Forms of Therapeutic Compounds and Uses Thereof Lapsed Aug 31, 2025 on the fee record High confidence | Kala Bio, Inc. | Lapsed Aug 31, 2025 on the fee record | High confidence |
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Kala Bio, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.